{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:50:55Z","timestamp":1794559855327,"version":"4.9.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T00:00:00Z","timestamp":1620345600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Without treatment, HIV infection in pregnant women is associated with adverse pregnancy outcomes. We compared adverse pregnancy outcomes among HIV-positive women on antiretroviral therapy (ART) and HIV-negative women who enrolled for antenatal care in selected health facilities in Maseru district, Lesotho.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      We enrolled a cohort of HIV-positive and HIV-negative women at their first antenatal visit and followed them through delivery. Study data on miscarriage, stillbirth, preterm birth, low birth weight and birth defects were collected through participant interviews and medical record abstraction. We used the Rao-Scott \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      test and the\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      test to assess differences in characteristics and outcomes between HIV-positive and HIV-negative women and generalized estimating equations for multivariable analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 614 HIV-positive and 390 HIV-negative pregnant women were enrolled in the study with delivery information on 571 (93.1%) and 352 (90.3%) respectively. In the delivery cohort, the median age at enrolment was 28 years for HIV-positive women and 23 years for HIV-negative women with median gestational ages of 20 and 21 weeks, respectively. A total of 149 singleton pregnancies had documented adverse pregnancy outcomes; 33 (9.6%) HIV-negative pregnancies and 116 (20.6%) HIV-positive pregnancies. Compared with their HIV-negative counterparts, HIV-positive women were more likely to experience an adverse pregnancy outcome, adjusted odds ratio (AOR) 2.6 [95% confidence interval (CI): 1.71\u20133.97]; an intrauterine death (miscarriage or stillbirth), AOR 2.64 [95% CI: 1.25\u20135.49]; or a low birth weight delivery, AOR 1.89 [95% CI: 1.16\u20133.09].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Adverse pregnancy outcomes remained 2\u20133 times higher among HIV-positive women compared with HIV-negative women despite universal ART.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000003174","type":"journal-article","created":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T02:03:00Z","timestamp":1621044180000},"page":"821-826","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":69,"title":["Adverse Pregnancy Outcomes Among HIV-positive Women in the Era of Universal Antiretroviral Therapy Remain Elevated Compared With HIV-negative Women"],"prefix":"10.1097","volume":"40","author":[{"given":"Vincent J.","family":"Tukei","sequence":"first","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Maseru, Lesotho"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather J.","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics, George Washington University Milken Institute School of Public Health, Washington, District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Greenberg","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Washington, District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramatlapeng","family":"Thabelo","sequence":"additional","affiliation":[{"name":"Ministry of Health, Maseru, Lesotho"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masepeli","family":"Nchephe","sequence":"additional","affiliation":[{"name":"Ministry of Health, Maseru, Lesotho"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsietso","family":"Mots\u2019oane","sequence":"additional","affiliation":[{"name":"Ministry of Health, Maseru, Lesotho"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matseliso","family":"Masitha","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Maseru, Lesotho"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mammatli","family":"Chabela","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Maseru, Lesotho"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majoalane","family":"Mokone","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Maseru, Lesotho"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Mofenson","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Washington, District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Guay","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Washington, District of Columbia"},{"name":"Department of Epidemiology, George Washington University Milken Institute School of Public Health, Washington, District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Appolinaire","family":"Tiam","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Washington, District of Columbia"},{"name":"Department of global public health and primary care, Center for International Health, University of Bergen, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,5,7]]},"reference":[{"key":"R1-20250922","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1471-0528.1998.tb10227.x","article-title":"The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis.","volume":"105","author":"Brocklehurst","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"R2-20250922","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1471-0528.2008.01672.x","article-title":"Maternal HIV status and pregnancy outcomes in northeastern Tanzania: a registry-based study.","volume":"115","author":"Habib","year":"2008","journal-title":"BJOG"},{"key":"R3-20250922","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S2352-3018(15)00207-6","article-title":"Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis.","volume":"3","author":"Wedi","year":"2016","journal-title":"Lancet HIV"},{"key":"R4-20250922","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1017\/S0950268818003345","article-title":"Impact of maternal HIV infection on pregnancy outcomes in southwestern China \u2013 a hospital registry based study.","volume":"147","author":"Yang","year":"2019","journal-title":"Epidemiol Infect"},{"key":"R5-20250922","doi-asserted-by":"crossref","first-page":"e19213","DOI":"10.1097\/MD.0000000000019213","article-title":"Maternal HIV infection and risk of adverse pregnancy outcomes in Hunan province, China: a prospective cohort study.","volume":"99","author":"Li","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R9-20250922","doi-asserted-by":"crossref","first-page":"e900","DOI":"10.1542\/peds.2006-1123","article-title":"Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: pediatric spectrum of HIV disease, 1989-2004.","volume":"119","author":"Schulte","year":"2007","journal-title":"Pediatrics"},{"key":"R10-20250922","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12884-016-0821-3","article-title":"Improved pregnancy outcomes with increasing antiretroviral coverage in South Africa.","volume":"16","author":"Moodley","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"key":"R11-20250922","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/QAI.0000000000001875","article-title":"Pregnancy outcomes in the era of universal antiretroviral treatment in sub-Saharan Africa (POISE Study).","volume":"80","author":"Dadabhai","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R12-20250922","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12884-017-1263-2","article-title":"Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda.","volume":"17","author":"Rempis","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"R13-20250922","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/ije\/dyx136","article-title":"Antiretroviral therapy use during pregnancy and adverse birth outcomes in South African women.","volume":"46","author":"Malaba","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R14-20250922","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1511691","article-title":"Benefits and risks of antiretroviral therapy for perinatal HIV prevention.","volume":"375","author":"Fowler","year":"2016","journal-title":"N Engl J Med"},{"key":"R15-20250922","doi-asserted-by":"crossref","first-page":"e0198447","DOI":"10.1371\/journal.pone.0198447","article-title":"Comparative safety and effectiveness of perinatal antiretroviral therapies for HIV-infected women and their children: systematic review and network meta-analysis including different study designs.","volume":"13","author":"Veroniki","year":"2018","journal-title":"PLoS One"},{"key":"R21-20250922","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/QAD.0000000000002222","article-title":"Perinatal outcomes associated with maternal HIV and antiretroviral therapy in pregnancies with accurate gestational age in South Africa.","volume":"33","author":"Santosa","year":"2019","journal-title":"AIDS"},{"key":"R22-20250922","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1097\/QAI.0000000000002082","article-title":"Brief report: high rates of adverse birth outcomes in HIV and syphilis coinfected women in Botswana.","volume":"81","author":"Shava","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R23-20250922","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/QAI.0000000000002087","article-title":"Stillbirth in women living with HIV delivering in the United Kingdom and Ireland: 2007-2015.","volume":"82","author":"Favarato","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R24-20250922","doi-asserted-by":"crossref","first-page":"e0178134","DOI":"10.1371\/journal.pone.0178134","article-title":"Effects of HIV infection on maternal and neonatal health in southern Mozambique: a prospective cohort study after a decade of antiretroviral drugs roll out.","volume":"12","author":"Gonz\u00e1lez","year":"2017","journal-title":"PLoS One"},{"key":"R25-20250922","doi-asserted-by":"crossref","first-page":"e804","DOI":"10.1016\/S2214-109X(18)30218-3","article-title":"Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study.","volume":"6","author":"Zash","year":"2018","journal-title":"Lancet Glob Health"},{"key":"R26-20250922","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1097\/QAD.0000000000002367","article-title":"Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis.","volume":"33","author":"Venkatesh","year":"2019","journal-title":"AIDS"},{"key":"R27-20250922","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1586\/14787210.2014.885837","article-title":"Antiretroviral therapy and preterm birth in HIV-infected women.","volume":"12","author":"Short","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R28-20250922","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/QAI.0000000000002072","article-title":"Risk factors for adverse birth outcomes in the PROMISE 1077BF\/1077FF trial.","volume":"81","author":"Sebikari","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R29-20250922","doi-asserted-by":"crossref","first-page":"e019022","DOI":"10.1136\/bmjopen-2017-019022","article-title":"Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis.","volume":"7","author":"Siemieniuk","year":"2017","journal-title":"BMJ Open"},{"key":"R30-20250922","doi-asserted-by":"crossref","first-page":"e172222","DOI":"10.1001\/jamapediatrics.2017.2222","article-title":"Comparative safety of antiretroviral treatment regimens in pregnancy.","volume":"171","author":"Zash","year":"2017","journal-title":"JAMA Pediatr"},{"key":"R31-20250922","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/QAD.0000000000001673","article-title":"Emulating a target trial of antiretroviral therapy regimens started before conception and risk of adverse birth outcomes.","volume":"32","author":"Caniglia","year":"2018","journal-title":"AIDS"},{"issue":"suppl 2","key":"R32-20250922","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/QAD.0000000000000231","article-title":"Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis.","volume":"28","author":"Ford","year":"2014","journal-title":"AIDS"},{"key":"R33-20250922","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/QAI.0000000000001922","article-title":"Birth defects after exposure to efavirenz-based antiretroviral therapy at conception\/first trimester of pregnancy: a multicohort analysis.","volume":"80","author":"Martinez de Tejada","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R35-20250922","doi-asserted-by":"crossref","first-page":"e25352","DOI":"10.1002\/jia2.25352","article-title":"Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects.","volume":"22","author":"Mofenson","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"R36-20250922","doi-asserted-by":"crossref","first-page":"e0231938","DOI":"10.1371\/journal.pone.0231938","article-title":"Placental growth disorders and perinatal adverse outcomes in Brazilian HIV-infected pregnant women.","volume":"15","author":"Dos Reis","year":"2020","journal-title":"PLoS One"},{"key":"R37-20250922","doi-asserted-by":"crossref","first-page":"684.e1","DOI":"10.1016\/j.ajog.2017.10.003","article-title":"Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV.","volume":"217","author":"Conroy","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R38-20250922","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2352-3018(16)30195-3","article-title":"Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis.","volume":"4","author":"Uthman","year":"2017","journal-title":"Lancet HIV"},{"key":"R39-20250922","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/tmi.13233","article-title":"Timing of combination antiretroviral therapy (cART) initiation is not associated with stillbirth among HIV-infected pregnant women in Malawi.","volume":"24","author":"Msukwa","year":"2019","journal-title":"Trop Med Int Health"},{"key":"R40-20250922","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/EDE.0000000000000772","article-title":"Timing of initiation of antiretroviral therapy and risk of preterm birth in studies of HIV-infected pregnant women: the role of selection bias.","volume":"29","author":"Stoner","year":"2018","journal-title":"Epidemiology"},{"key":"R41-20250922","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1093\/jpids\/piy006","article-title":"Effect of gestational age at tenofovir-emtricitabine-efavirenz initiation on adverse birth outcomes in Botswana.","volume":"7","author":"Zash","year":"2018","journal-title":"J Pediatric Infect Dis Soc"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003174","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T13:03:11Z","timestamp":1758546191000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,7]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003174","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,7]]}}}